Dr. Christopher Alan Slapak MD
Hematologist-Oncologist | Hematology & Oncology
The Wishard Hospital Hematology Clinic 1050 Wishard Blvd Indianapolis IN, 46202About
Dr. Christopher Slapak is a hematologist oncologist practicing in Indianapolis, IN. Dr. Slapak specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med 1984
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell
- Reversal of multidrug resistance with LY335979: functional analysis of P-glycoprotein-mediated transport activity and its modulation in vivo.
- A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
- A phase I trial of a potent P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), administered orally in combination with doxorubicin in patients with advanced malignancies.
- Identification and characterization of the canine multidrug resistance-associated protein.
- Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts.
- Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol.
- Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters.
- A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy.
- An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines.
- Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignancies.
- Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity.
- Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic study.
- Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
- Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors.
Dr. Christopher Alan Slapak MD's Practice location
Dr. Christopher Alan Slapak MD's reviews
Write ReviewRecommended Articles
- How is Multiple Myeloma Diagnosed?
Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...
- Teen Finds Strength to Give Back After Battling Lymphoma
Ayden Mills is a 14-year-old middle school student residing in Vancouver, Washington. It’s easy to wonder how someone could be an inspiration at such a young age, but what Mills has gone fought through is nothing short of amazing. Mills’s story shows how it is possible to fight through even the...
- Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a Cause
Everyone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...
- Facts About Multiple Myeloma
Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...
- New Study Discovers How Lymphoma Affects Survivors’ Ability to Work
Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
Nearby Providers
- Dr. William Dugan MD115 W 19th St Indianapolis IN 46202
- Dr. Yaman Suleiman MD1001 W 10th St Indianapolis IN 46202
- Dr. Attaya Suvannasankha M.D.1044 W Walnut St Indianapolis IN 46202
- Dr. Elena G Chiorean M.D.535 Barnhill Dr Indianapolis IN 46202
- Dr. Stephanie Ann Wagner MD535 Barnhill Dr Indianapolis IN 46202
- Dr. Jay Allen Gaddy M.D.1481 W 10th St Indianapolis IN 46202